Uses of Tolbupas

Tolbupas is indicated to relieve symptoms of dyspnea caused by airway obstruction in patients with acute bronchitis, bronchial asthma, pneumothorax, chronic bronchitis... Use, notes when using Tolbupas through the article below.

Tolbupas medicine is made in the form of a skin patch containing 0.5mg of the active ingredient Tulobuterol. Tulobuterol has a bronchodilator effect by stimulating Beta 2 - Adrenergic receptors of bronchial smooth muscle, activating Adenyl Cyclase closely related to Beta 2 - Adrenergic receptors. From there, ATP is converted to cyclic AMP. Tulobuterol is used to improve respiratory function, treat cough without affecting heart rate. The selective effect on tracheal muscles is much higher than that of the oral Beta 2 agonists Salbutamol, Isopreteranol, Fenoterol and Procaterol... Tulobuterol has been shown to increase tracheal ciliary mobility and suppress cough. .
Tolbupas 0.5 is indicated in the treatment of shortness of breath caused by obstructive airway disease in patients with acute bronchitis, bronchial asthma, pneumothorax, chronic bronchitis.

Tolbupas is used by the skin. Patients should use the Tolbupas skin patch as follows:
Clean the skin to be patched and dry; Remove the pad on the patch and stick it on the damaged skin; Use your hands to rub the patch evenly to help the drug absorb better. The recommended dose of Tolbupas according to the age of the patient is as follows:
Adults and children over 9 years old: Take 2mg/day; Children from 6 months old to 3 years old: Use 0.5mg/day; Children from 3 years old to 9 years old: 1mg/day.

Tolbupas medicine can cause some unwanted effects as follows:
On the skin - soft tissues: Erythema, contact dermatitis, itching at the skin of the drug; On the circulatory and cardiovascular systems: Palpitations ; Whole body: Trembling. Patients should notify the treating doctor when experiencing unwanted effects during treatment with Tolbupas.

Tolbupas is contraindicated in patients with hypersensitivity to Tulobuterol or any of its ingredients. Use caution when using Tolbupas in patients with hyperthyroidism, hypertension, heart disease, diabetes, atopic dermatitis, the elderly. For drivers, operating machines: Tolbupas 0.5 can cause symptoms of dizziness, tremors affecting the concentration of drivers, operating machines and heavy workers. For pregnant women, lactating women: There are no studies on the safety and effectiveness of Tolbupas 0.5 in these subjects. Store Tolbupas at room temperature, away from sunlight and high humidity.

Tolbupas may interact with the following drugs:
Catechilamine group drugs: Isoprotenenole, Adrenalin; Xanthin derivatives; Anti-inflammatory steroids: Hydrocortisone, Prednisolone. Drug interactions occur that increase the risk of having an effect and reduce the therapeutic effect of Tolbupas, so to ensure safety and effectiveness in treating patients, it is necessary to inform the doctor about the drugs and foods that are being used. used before taking Tolbupas.